AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+111.0%
5Y CAGR+23.4%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+111.0%/yr
vs -11.0%/yr prior
5Y CAGR
+23.4%/yr
Recent acceleration
Acceleration
+122.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $4.57B | +57.8% |
| 2024 | $2.90B | +106.2% |
| 2023 | $1.40B | +188.8% |
| 2022 | $486.40M | -34.7% |
| 2021 | $744.90M | -53.4% |
| 2020 | $1.60B | -1.8% |
| 2019 | $1.63B | +109.7% |
| 2018 | $775.70M | +16.3% |
| 2017 | $667.20M | -74.0% |
| 2016 | $2.57B | - |